31 Mar 2019
Assets187.51
Total Income206.80
EBITDA34.30
Profit After Tax20.54
NET Worth79.70
Reserves and Surplus71.67
Total Borrowing77.15
At a glance
Updated 2026-08-23The shares listed at ₹2,111.85, a 95.00% move from the issue price. Tatva Chintan Pharma is a Mainboard IPO with an issue size of ₹500.00 crore, proposed for listing on BSE, NSE. The offer opens on 16th Jul 2021 and closes on 20th Jul 2021. The issue structure includes a fresh issue of ₹225.00 crore and an offer-for-sale component of ₹275.00 crore. The current listing schedule points to 29th Jul 2021.
Issue details
Listing atBSE, NSE
Issue typeBook Build Issue
Issue size₹500.00 Cr
Fresh issue₹225.00 Cr
Offer for sale₹275.00 Cr
Face value₹10
Price band₹1,073.00–₹1,083.00
Allotment26th Jul 2021
Listing29th Jul 2021
Listing performance
Full performance ↗Issue price₹1,083.00
Listing price₹2,111.85
Current price—
Listing gain95.00%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹1,110.00
GMP / upper price102.49%
Est. listing₹2,193.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens16th Jul 2021
Closes20th Jul 2021
Allotment26th Jul 2021
Refund27th Jul 2021
Demat28th Jul 2021
Listing29th Jul 2021
Subscription demand
Full bidding ↗Total180.36×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 13 | ₹14,079 |
Company
Incorporated1996
Use of proceeds
| Object | Amount |
|---|---|
| Funding capital expenditure requirements for expansion of our Dahej Manufacturing Facility | ₹147.10 Cr |
| Funding capital expenditure requirements for upgradation at our R&D facility in Vadodara; and | ₹23.97 Cr |
| General corporate purposes | ₹36.21 Cr |
Financials
Full financials ↗31 Mar 2020
Assets248.94
Total Income264.62
EBITDA56.34
Profit After Tax37.79
NET Worth117.69
Reserves and Surplus109.66
Total Borrowing90.69
31 Mar 2021
Assets314.80
Total Income306.29
EBITDA71.64
Profit After Tax52.26
NET Worth165.96
Reserves and Surplus145.88
Total Borrowing90.25
Trend chart₹ crore
KPIs
| KPI | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | ees payable to the BRLMs and commissions (including underwriting commission, brokerage and selling commission | 19.78 |
| 2 | Selling commission payable to SCSBs for Bids directly procured by them and processing fees payable to SCSBs for Bids (other than Bids submitted by RIIs using the UPI Mechanism) procured by the Members of the Syndicate, the Registered Brokers, CRTAs or CDPsand submitted to SCSBs for blocking, Bankers to the Offer, fees payable to the Sponsor Bank for Bids made by RIBs and Selling commission and uploading charges payable to Members of the Syndicate, RTAs, CDPs and Reg. Brokers | 6.07 |
| 3 | Processing fees payable to the Sponsor Bank | 1.36 |
| 4 | Fees payable to Registrar to the Offer | 0.47 |
| 5 | Printing and stationery expenses | 1.65 |
| 6 | Advertising and marketing expenses | 2.95 |
| 7 | Listing fees, SEBI fees, BSE and NSE processing fees, book-building software fees, and other regulatory expenses | 2.94 |
| 8 | Fees payable to legal counsel | 2.51 |
Issue expenses
| Expense | Amount |
|---|---|
| ees payable to the BRLMs and commissions (including underwriting commission, brokerage and selling commission | ₹19.78 Cr |
| Selling commission payable to SCSBs for Bids directly procured by them and processing fees payable to SCSBs for Bids (other than Bids submitted by RIIs using the UPI Mechanism) procured by the Members of the Syndicate, the Registered Brokers, CRTAs or CDPsand submitted to SCSBs for blocking, Bankers to the Offer, fees payable to the Sponsor Bank for Bids made by RIBs and Selling commission and uploading charges payable to Members of the Syndicate, RTAs, CDPs and Reg. Brokers | ₹6.07 Cr |
| Processing fees payable to the Sponsor Bank | ₹1.36 Cr |
| Fees payable to Registrar to the Offer | ₹0.47 Cr |
| Printing and stationery expenses | ₹1.65 Cr |
| Advertising and marketing expenses | ₹2.95 Cr |
| Listing fees, SEBI fees, BSE and NSE processing fees, book-building software fees, and other regulatory expenses | ₹2.94 Cr |
| Fees payable to legal counsel | ₹2.51 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- ICICI Securities Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-23.